KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation and Depletion (2016 - 2021)

Arbutus Biopharma's Depreciation and Depletion history spans 7 years, with the latest figure at $427000.0 for Q4 2021.

  • On a quarterly basis, Depreciation and Depletion fell 12.32% to $427000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $1.8 million, a 11.38% decrease, with the full-year FY2025 number at $363000.0, down 73.7% from a year prior.
  • Depreciation and Depletion hit $427000.0 in Q4 2021 for Arbutus Biopharma, down from $447000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for ABUS hit a ceiling of $620000.0 in Q4 2017 and a floor of $334000.0 in Q1 2017.
  • Historically, Depreciation and Depletion has averaged $498350.0 across 5 years, with a median of $500500.0 in 2020.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 103.78% in 2017 and later dropped 18.71% in 2018.
  • Tracing ABUS's Depreciation and Depletion over 5 years: stood at $620000.0 in 2017, then fell by 18.71% to $504000.0 in 2018, then increased by 0.6% to $507000.0 in 2019, then decreased by 3.94% to $487000.0 in 2020, then fell by 12.32% to $427000.0 in 2021.
  • Business Quant data shows Depreciation and Depletion for ABUS at $427000.0 in Q4 2021, $447000.0 in Q3 2021, and $436000.0 in Q2 2021.